Special Issue "In Honour of Marcel Tanner, Parasitologist Extraordinaire"
Deadline for manuscript submissions: closed (1 December 2022) | Viewed by 11409
2. (Formerly UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization), Geneva, Switzerland
Interests: geospatial epidemiology; schistosomiasis; food-borne trematodes; COVID-19
Marcel Tanner is an important figure in global health research and implementation. Trained as a parasitologist and public health specialist, he skilfully combines various fields of expertise: from basic to operational research, from the molecular level to health systems strengthening, from infectious to non-communicable diseases, from animal to human health (“One health”). Marcel Tanner’s work and lifetime achievements epitomise the crucial iterative process from the “bench to the field”, always striving to implement scientific findings to improve the fate of neglected populations and underperforming health systems. Marcel Tanner is a role model for how to encourage and create scientific institutions in low- and middle-income countries. He was a major driver behind the development of the Ifakara Health Institute (IHI) in Tanzania, after which other major research centres in Sub-Saharan Africa are modelled, such as the Centre Suisse de Recherches Scientifiques in Côte d’Ivoire, the Centre de Support en Santé Internationale in the Chad, and the Manhiça Health Research Centre in Mozambique. With regard to research and elimination of specific infectious diseases, Marcel Tanner has produced key papers in the fields of schistosomiasis and malaria. He was the principal investigator overseeing the first malaria vaccine trial in Sub-Saharan Africa (SPf66) and—together with IHI and other partners—led the clinical trials for the malaria vaccine candidate RTS,S/AS01E. Marcel Tanner has authored/co-authored over 800 original research papers and is one of the most productive scholars in health systems research between 1900 and 2012 (rank 6). He supervised many PhD, MD and MSc, MIH, and MPH students and has paved the way for new models of research partnership.
Dr. Robert Bergquist
Dr. Lukas Meier
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- global health
- public health
- institution building
- capacity building
- health systems
- research partnership